SWOG clinical trial number
SWOG-9059 (E-1392) (INT-0126)
Phase III Comparison of Standard Radiotherapy, versus Radiotherapy plus Simultaneous Cisplatin, versus Split-Course Radiotherapy plus Simultaneous Cisplatin and 5-Fluorouracil, in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck
Closed
Phase
Published
Abbreviated Title
Phase III Comparison of Standard Radiotherapy, versus Radiotherapy plus Simultaneous Cisplatin, versus Split-Course Radiotherapy plus Simultaneous Cisplatin and 5-Fluorouracil, in Patients with…
Activated
06/15/1992
Closed
11/29/1999
Research committees
Head and Neck Cancer
Publication Information Expand/Collapse
2003
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
2000
A phase III comparison of standard radiation thereapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-Fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC